Life Science Consulting That Drives Better Health Decisions
Generating knowledge and providing greater understanding so that life science and healthcare stakeholders—developers, regulators, payers, providers, and patients—can make better decisions.
Service Categories
Strategic Solutions
Service Categories
When you need substantiated, authoritative evidence, turn to our academically trained, credentialed researchers. We know how and when to apply the appropriate research methodologies and novel approaches to support your real-world applications and situations. Explore our areas of expertise to learn how we can generate the evidence you need to support decision making throughout the lifecycle of your product.
Strategic Solutions
We have a collaborative team of experts ready to provide strategic support aligned to the key opportunities and trends facing pharmaceutical and bioscience companies today. Explore how we can help you create a development and communications plan to leverage your data and address barriers to accessing and using your products in the real world.
Featured Content
-
EVENT
ISPOR Europe
We are pleased to be a year-round sponsor of ISPOR. Our team will also be attending, speaking, and presenting in Glasgow. Take a look at our schedule below and meet us at booth #607.
-
RESOURCE
EU Joint Clinical Assessment for Orphan Drugs
Methodological Challenges, Solutions, and Early Learnings
Are you prepared to navigate the complexities of Joint Clinical Assessment (JCA) in the EU for your rare disease product? Join our webinar to hear from our panel of experts with extensive experience supporting clients with their EU JCA strategy, training, PICO prediction, and submission development. With years of deep expertise in orphan drugs, our panel will guide you through the essential steps to develop a successful JCA strategy in rare disease.
-
RESOURCE
Economic Modeling Challenges in Rare Diseases
When seeking approval for rare disease products, demonstrating value for therapies can be a challenge. The limited amount of data available affects the feasibility of developing models that meet good practice recommendations for health technology assessment submissions. Join us for this webinar where our health economics consulting experts will discuss different approaches for developing a rigorous economic model structure for rare disease research that can help you gain orphan drug reimbursement.
View this webinar where you’ll learn:
-
RESOURCE
Artificial Intelligence in Health Science: Advancing Research Responsibly and Ethically
Intelligence have significantly impacted research, promising new efficiencies and insights that accelerate discovery. While this technology holds great promise, it also comes with risk. We help clients understand how to effectively use AI in a rapidly changing landscape.
At RTI Health Solutions, we prioritize responsible AI use by adhering to 5 key principles.
This website uses Google Analytics to collect data to track and examine the use of this website, to prepare reports on its activities, and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network. Learn how to opt out of Google Analytics tracking.